Back to VANGUARD GROUP INC VANGUARD GROUP INC

CRMDCRMD
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in CORMEDIX INC

As of its last 13F, for Q4 2025, Vanguard Group held 4,499,010 shares of CRMD (Cormedix), worth $52.3M. It increased the position by 521,352 shares (+13.1%) from Q3 2025. Vanguard Group held CRMD from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$52.3M

Current Shares

4.5M

Total Value Change

+$27.5M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
4.5M
+13.1%
$52.3M0.0%$11.63
33
2025-Q3
Decreased
4M
-8.0%
$46.3M0.0%$11.63
0
2025-Q2
Increased
4.3M
+18.6%
$53.3M0.0%$12.32
35
2025-Q1
Increased
3.6M
+7.9%
$22.5M0.0%$6.16
31
2024-Q4
Increased
3.4M
+10.1%
$27.4M0.0%$8.10
32
2024-Q3
First report
3.1M
-
$24.8M0.0%$8.08
0

Other major holders of CRMD: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used